Thermo Fisher Scientific ... (TMO)
Thermo Fisher Scientific Inc. (TMO) Stock Price, Analysis & Data
| Bid | 587.98 |
| Market Cap | 217.52B |
| Revenue (ttm) | 46.34B |
| Net Income (ttm) | 6.97B |
| Beta | 0.85 |
| EPS (ttm) | 18.59 |
| PE Ratio (ttm) | 32.06 |
| Forward PE | 21.38 |
| P/B (ttm) | 4.13 |
| P/S (ttm) | 4.69 |
| Earnings Date | Oct 21, 2026 |
| Ask | 587.89 |
| Volume | 1,057,632 |
| Avg. Volume (20D) | 2,266,763 |
| Open | 592.11 |
| Previous Close | 595.89 |
| Day's Range | 587.51 - 594.74 |
| 52-Week Range | 435.27 - 643.99 |
| Analyst | Buy |
| Price Target | 642.5 (9.21%) |
| Dividends | $1.88 (0.32%) |
| Ex-Dividend Date | Sep 15, 2026 |
About TMO
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research;...
Financial Performance
In 2025, Thermo Fisher Scientific's revenue was 44.56B, an increase of 3.91% compared to the previous year's 42.88B. Earnings were 6.7B, an increase of 5.82%.
Financial StatementsAnalyst Forecast
According to 26 analyst ratings, the average rating for TMO stock is "Buy". The 12-month stock price forecast is 642.5, which is upside of 9.21% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
